Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The D1-family dopamine receptors, comprising the D1 and D5 subtypes, are a class of G protein-coupled receptors (GPCRs) that play a fundamental role in the central nervous system and peripheral tissues (UniProt, 2023). These receptors are characterized by their coupling to stimulatory G proteins (Gs/olf), which activate adenylyl cyclase to increase intracellular cAMP levels, thereby modulating neuronal excitability and synaptic plasticity (StatPearls, 2024). In the brain, they are heavily involved in regulating motor activity, executive functions, and reward-related behaviors, while in the periphery, they contribute to the regulation of blood pressure and renal function (IUPHAR/BPS, 2023). Dysregulation of D1-family signaling is implicated in several neuropsychiatric and neurological conditions, including Parkinson's disease, schizophrenia, and ADHD (PubMed, 2022). Pharmacological targeting of these receptors involves agonists like fenoldopam for treating hypertension, as well as antagonists, often as part of a broader antipsychotic profile, to manage psychotic symptoms (PubChem, 2024). Understanding the distinct expression patterns and functional roles of D1 and D5 receptors remains a key area of research for developing more selective and effective therapeutic interventions (NIH, 2023).
D1-family receptors primarily couple to Gs or Golf proteins, which stimulate adenylyl cyclase activity, leading to an increase in the second messenger cyclic adenosine monophosphate (cAMP) and subsequent activation of protein kinase A (PKA) (StatPearls, 2024).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine D1-like receptor family (D1-like receptors).